This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
GU Onc Weekly
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
UroAlert - GU Oncology Weekly
Sent on 04 June 2026
Rethinking Treatment Pathways in Recurrent Low-Grade NMIBC
Sent on 04 June 2026
ASCO 2026 Radioligand Therapy Advances Across Prostate Cancer
Sent on 02 June 2026
ASCO 2026 Prostate Cancer Advances Across the Disease Continuum
Sent on 01 June 2026
ASCO 2026 Advancing Curative Strategies in Bladder and Kidney Cancer
Sent on 01 June 2026
Key Prostate Cancer Insights From Day 3 at ASCO
Sent on 31 May 2026
ASCO 2026 Matching Prostate Cancer Treatment to Risk, Response, and Patient Benefit
Sent on 31 May 2026
Novel Approaches to Curing Bladder and Kidney Cancer at ASCO 2026
Sent on 30 May 2026
Emerging RCC and Bladder Cancer Data From ASCO Day 1
Sent on 30 May 2026
UroAlert - GU Oncology Weekly
Sent on 28 May 2026
Navigating Treatment Decisions as Prostate Cancer Progresses
Sent on 28 May 2026
Emerging Strategies Shaping PSMA-Directed Prostate Cancer Care
Sent on 27 May 2026
Key GU Oncology Data to Watch at ASCO 2026
Sent on 26 May 2026
Treatment Intensification, Monitoring, and Emerging Therapies in Prostate Cancer
Sent on 24 May 2026
Making Bladder-Sparing Decisions in High-Risk NMIBC
Sent on 23 May 2026
AUA-IBCG Bladder Cancer Forum: Debating the Future of Bladder Cancer Care
Sent on 22 May 2026
UroAlert - GU Oncology Weekly
Sent on 21 May 2026
Emerging Strategies in NMIBC from AUA 2026
Sent on 19 May 2026
AUA 2026 Advances in NMIBC Treatment and Risk Stratification
Sent on 17 May 2026
AUA 2026 Updates in MIBC and Advanced Urothelial Cancer
Sent on 17 May 2026
AUA 2026 Highlights Evolving Strategies in Prostate Cancer Care
Sent on 16 May 2026
AUA 2026 Updates in Kidney-Sparing and Bladder Cancer Strategies
Sent on 16 May 2026
AUA 2026 Plenary Headlines: Durvalumab (POTOMAC) and Pembrolizumab Combined with BCG in High-Risk NMIBC
Sent on 16 May 2026
American Urological Association (AUA) 2026 Practice-Changing, Paradigm-Shifting Clinical Trials in Urology and NMIBC Highlights
Sent on 15 May 2026
UroAlert - GU Oncology Weekly
Sent on 14 May 2026
Understanding Radiopharmaceutical Therapy in Prostate Cancer: From Mechanism to Clinical Practice
Sent on 14 May 2026
Key Bladder and Prostate Cancer Data to Watch at AUA 2026
Sent on 13 May 2026
Rethinking Bladder-Sparing Strategies After BCG Exposure or Failure
Sent on 12 May 2026
You’re Invited to a Bladder Cancer Patient Experience Discussion on May 14
Sent on 09 May 2026
UroAlert - GU Oncology Weekly
Sent on 07 May 2026
Overcoming Resistance in Advanced Prostate Cancer
Sent on 07 May 2026
Optimizing Radioligand Therapy for Advanced Prostate Cancer
Sent on 06 May 2026
Refining Treatment Selection Across Advanced Prostate Cancer
Sent on 05 May 2026
Optimizing Long-Term Management in Advanced Prostate Cancer
Sent on 04 May 2026
APCCC 2026 Closing Gaps in Precision Prostate Cancer Care
Sent on 02 May 2026
APCCC 2026 Session 3 Highlights Rethinking Treatment Strategy in mHSPC
Sent on 01 May 2026
APCCC 2026 Session 1 Highlights: Matching Treatment Intensity to Risk in Prostate Cancer
Sent on 30 April 2026
UroAlert - GU Oncology Weekly
Sent on 30 April 2026
Evolving Care for Low-Grade Intermediate-Risk NMIBC
Sent on 30 April 2026
Managing High-Risk Biochemical Recurrence Before Metastatic Progression
Sent on 29 April 2026
Using PSMA PET to Guide Care in nmCRPC
Sent on 27 April 2026
How AI and Genomics Are Changing Prostate Cancer Care
Sent on 24 April 2026
UroAlert - GU Oncology Weekly
Sent on 23 April 2026
Defining Progression and Response in Advanced Prostate Cancer
Sent on 23 April 2026
Translating Emerging Science into Prostate Cancer Care
Sent on 22 April 2026
Targeting Epigenetics and Advancing Precision Care in Prostate Cancer
Sent on 21 April 2026
Balancing Efficacy and Toxicity in Advanced Prostate Cancer Care
Sent on 17 April 2026
UroAlert - GU Oncology Weekly
Sent on 16 April 2026
Balancing Treatment Intensification and Quality of Life in mHSPC
Sent on 16 April 2026
Advancing Decision-Making Across Localized Prostate Cancer Care
Sent on 15 April 2026
Page
of 58
Display #
5
10
15
20
25
30
50
100
Results 1 - 50 out of 2899
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
